18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF

The present invention relates to an 18F-labelled compound, and a use thereof. The compound selectively binds to a prostate-specific membrane antigen (PSMA), and enables the acquisition of clear prostate cancer images in a short time when used in positron emission tomography (PET).

Saved in:
Bibliographic Details
Main Authors LIM, SANG MOO, LEE, KYO CHUL, YOO, RAN JI, PARK, JI AE, LEE, BYOUNG SE, CHU, SO YOUNG, KIM, MIN HWAN, CHI, DAE YOON, JUNG, WOON JUNG, JEONG, HYEON JIN, LEE, YONG JIN, KIM, MI HYUN
Format Patent
LanguageEnglish
Polish
Published 12.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an 18F-labelled compound, and a use thereof. The compound selectively binds to a prostate-specific membrane antigen (PSMA), and enables the acquisition of clear prostate cancer images in a short time when used in positron emission tomography (PET).
Bibliography:Application Number: PL20180820848T